School of Medicine
Showing 1,081-1,090 of 1,210 Results
-
Jennifer Tsai
Adjunct Clinical Instructor, Pediatrics - Hematology & Oncology
BioJennifer is a researcher in clinical development of novel therapeutics for hematologic diseases. She has a special interest in rare pediatric disorders.
-
Philip S. Tsao, PhD
Professor (Research) of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsOur primary interests are in the molecular underpinnings of vascular disease as well as assessing disease risk. In addition to targeted investigation of specific signaling molecules, we utilize global genomic analysis to identify gene expression networks and regulatory units. We are particularly interested in the role of microRNAs in gene expression pathways associated with disease.
-
Chi-Ho Ban Tsui
Adjunct Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
BioDr. Tsui completed his medical training at Dalhousie University in Halifax in 1995, following his Master of Science in Pharmacy in 1991. These degrees followed a Diploma in Engineering and a Bachelor of Science in both Mathematics and Pharmacy. After 16 years of practice at the University of Alberta Hospital and Stollery Children’s Hospital, Dr. Tsui was recruited to Stanford University in 2016.
Dr. Tsui is an avid and internationally recognized researcher. During his residency, Dr. Tsui developed an interest in improving the accuracy of epidural catheter placement and was issued a U.S. patent for his research. Dr. Tsui has expanded his research on ultrasound in regional anesthesia, with particular relevance to peripheral nerve block performance. Dr. Tsui is also responsible for developing the E-Catheter catheter-over-needle kit for use during peripheral nerve blocks. The primary objective of his research is to transform regional anesthesia from an “art” into a reliable and reproducible “science” by further exploring the fundamental scientific and clinical aspects of electrophysiological signal monitoring and integrating this with the latest advances in ultrasound.
Academically, Dr. Tsui received the 2005 John Bradley Young Educator Award from the Canadian Anesthesiologists' Society. This award recognizes his work as a clinical educator, researcher, and anesthesia trainee role model. While in Canada, Dr. Tsui was the only Canadian invited to write a chapter for a prestigious American anesthesia textbook - Clinical Anesthesia (Barash). Dr. Tsui wrote the first textbook on Ultrasound and Nerve Stimulation-Guided Regional Anesthesia. Dr. Tsui also co-authored the first pediatric textbook on the subject, the Pediatric Atlas of Ultrasound- and Nerve Stimulation-Guided Regional Anesthesia. Dr. Tsui co-authored and edited "Principles of Airway Management" and "Complications in Regional Anesthesia." From 2006 to 2018, Dr. Tsui served on the editorial board of the Canadian Journal of Anesthesia. Dr. Tsui is currently the editor of the Regional Anesthesia and Pain Medicine.
Dr. Tsui has received the Alberta Heritage Foundation for Medical Research (AHFMR) Clinical Scholar award and has previously received research awards and grants from the Canadian Institutes of Health Research (CIHR), Canadian Anesthesiologists’ Society, AHFMR, and University of Alberta. In 2015, the CAS Research Recognition Award, a prestigious award presented by the Canadian Anesthesiologists’ Society, was awarded to Dr. Tsui "in recognition of significant research contributions to regional anesthesia, acute pain management, and pediatric anesthesia in Canada and around the world". In 2022, the American Society of Regional Anesthesia and Pain Medicine (ASRA) awarded Dr. Tsui the Distinguished Service Award. This prestigious annual award honors individuals who have made remarkable contributions to the field of regional anesthesia and pain medicine
In 2025, in celebration of its 50th anniversary, ASRA honored Prof. Ban C.H. Tsui with the prestigious Gaston Labat Award. Presented annually since 1977 to recognize exceptional contributions to regional anesthesia, ASRA specifically chose Prof. Tsui as the 2025 recipient to mark this significant milestone.
Dr. Tsui was a full professor and is now an adjunct professor in the Department of Anesthesiology, Perioperative, and Pain Medicine at Stanford University. Recently, the Chinese University of Hong Kong, Shenzhen, recruited Dr. Tsui as an associate dean (Clinical Innovation & Translational Research), Chair, and Chief of the Department of Anesthesiology, Critical Care, and Pain Medicine. He was then shortly promoted to the position of Executive Associate Dean of the School of Medicine. Dr. Tsui is also an Honorary Full Professor at the Chinese University of Hong Kong. -
Jason Tucciarone, MD, PhD
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioJason Tucciarone, MD, PhD is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at Stanford School of Medicine. A neuroscientist and psychiatrist, he leads a laboratory focused on uncovering the biological mechanisms of mental illness and developing novel therapies for mood disorders and addiction. His research centers on defining new cell types and evolutionarily conserved neural circuits involved in emotional processing, with the goal of identifying new therapeutic entry points. Using optogenetic, chemogenetic, neuroimaging, and behavioral approaches in mouse models of addiction, his lab investigates vulnerable brain circuitry underlying opioid use disorder. He also works and collaborates with the Depression Research Clinic, participating in academic and industry sponsored clinical trials investigating novel antidepressant therapies.
Clinically, Dr. Tucciarone works in Stanford’s Neuropsychiatry Clinic, where he treats patients with complex presentations at the interface of psychiatry and neurology, with particular interest in functional neurological disorders. He also sees a small cohort of psychotherapy patients in the Individual Psychotherapy Clinic and works shifts on Stanford’s inpatient psychiatry units.
Dr. Tucciarone completed his psychiatry training through Stanford’s Research Residency Track, where he conducted postdoctoral research under the supervision of Drs. Robert Malenka and Alan Schatzberg. During residency, his research examined neural circuits recruited during opioid withdrawal and explored strategies to enhance the anti-suicidal effects of ketamine through μ-opioid receptor partial agonism.
He received his bachelor’s degree in biology and philosophy from Union College, followed by three years as a Post-Baccalaureate IRTA fellow at the National Institute of Neurological Disorders and Stroke, where he developed MRI-reportable contrast agents to map neuronal connectivity. He then entered the Medical Scientist Training Program (MD/PhD) at Stony Brook University, completing his PhD in neuroscience under the mentorship of Dr. Josh Huang at Cold Spring Harbor Laboratory. His doctoral work used mouse genetic approaches to dissect excitatory and inhibitory cortical circuits, with a focus on chandelier interneurons in the prefrontal cortex.
In addition to his research and clinical work, Dr. Tucciarone is deeply committed to teaching and mentorship. During residency, he helped restructure neuroscience education for trainees and currently teaches introductory lectures on the neuroscience of addiction, PTSD, psychosis, and mood disorders. He leads resident group supervision in introductory psychodynamic psychotherapy and supervises undergraduates, medical students, residents, and clinical fellows in psychiatry clinics. -
Mirko Uljarevic
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioI am a medically trained researcher focused academic with a background in developmental psychopathology, psychometrics and big data science. My research takes a life-span perspective and is driven by the urgent need to improve outcomes for people with autism and other neuropsychiatric (NPD) disorders and neurodevelopmental conditions (NDD). My primary research interest has focused on combining cutting-edge psychometric procedures and a big data approach to better understand structure of clinical phenotypes across autism and other NPD and NDD and on using this knowledge to improve existing and develop new clinical assessments that are more effective for screening and diagnosis, tracking the natural and treatment-related symptom progression and for use in genetic and neurobiological studies. In addition to my focus on the development of outcome measures, I have collaborated with leading psychopathology researchers and groups in the United States, Europe and Australia on numerous projects spanning a range of topics including genetics, treatment and employment, with a particular focus on understanding risk and resilience factors underpinning poor mental health outcomes in adolescents and adults. Most recently, through several competitively funded projects, I have led the statistical analyses to uncover the latent structure of social and communication and restricted and repetitive behaviors (RRB) clinical phenotypes across NPD and NDD. These findings have enabled us to (i) start capturing and characterizing a highly variable social functioning phenotype across a range of disorders and understanding mechanisms underpinning this variability, (ii) combine phenotypic and genetic units of analyses to advance our understanding of the genetic architecture of RRB, and (iii) focus on identification and characterization of subgroups of individuals that share distinct symptom profiles and demonstrate clinical utility and neurobiological validity. Importantly, this work has provided key information for developing a programmatic line of research aimed at developing novel, comprehensive assessment protocols that combine parent and clinician reports, objective functioning indicators and incorporate state-of-the-art psychometric, mobile and connected technologies and procedures.
I am a co-director of the recently established Program for Psychometrics and Measurement-Based Care (https://med.stanford.edu/sppmc.html) that aims to bring together world-leading expertise in clinical science, psychometrics, and big data analytics to bridge the gap between the science of measurement development and clinical practice and bring improvements to both clinical care and research. -
Ndidi Unaka
Clinical Professor, Pediatrics
BioDr. Unaka is the inaugural Chief Health Equity Officer (CHEO) for Stanford Medicine Children’s Health (SMCH) and a Clinical Professor in the Department of Pediatrics at Stanford University School of Medicine. Prior to her transition to SMCH in July 2024, Dr. Unaka was a faculty member in the Division of Hospital Medicine at Cincinnati Children's Hospital. In addition to her clinical role as a pediatric hospitalist, Dr. Unaka served as the Associate Program Director of the Pediatric Residency Program from 2011 – January 2022. She served as the medical director of a 48- bed inpatient unit primarily for patients admitted to the Hospital Medicine service. In this role, Dr. Unaka was involved in several equity-oriented quality improvement initiatives which included work to identify, and address hunger among caregivers of hospitalized children insured by Medicaid.
Dr. Unaka worked on institution-level community health initiatives at Cincinnati Children’s. She served as the Medical Director of Quality Improvement and Data Analytics for Cincinnati Children’s Medicaid- focused, accountable care organization (HealthVine). In this role, she developed and led initiatives designed to improve the quality and efficiency of health care delivery to HealthVine’s patient population and helped lead the change management associated with the movement toward a population-health care model that improves quality, narrows equity gaps, streamlines care, and reduces costs. She helped define appropriate health care delivery, equity, and population health measures and quality benchmarks. Additionally, Dr. Unaka was a faculty lead within Cincinnati Children's Fisher Child Health Equity Center, and she specifically focused on working with operations leaders to ensure equity was embedded within all strategic plans, goals, and metrics across all sites of care. Dr. Unaka partnered with several colleagues to lead system-wide quality improvement initiatives including work accelerated via learning networks. She was the co-lead of Cincinnati Children's Health Equity Network (HEN), an initiative borne out of the pursuit of excellent and equitable health outcomes for youth in Greater Cincinnati. The HEN supports clinical teams seeking to eliminate disparities in child health outcomes by race, ethnicity, and/or socioeconomic status via targeted interventions and best practices by addressing both medical and social factors known to confer poor health outcomes. -
Alexander Eckehart Urban
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator) and of Genetics
Current Research and Scholarly InterestsComplex behavioral and neuropsychiatric phenotypes often have a strong genetic component. This genetic component is often extremely complex and difficult to dissect. The current revolution in genome technology means that we can avail ourselves to tools that make it possible for the first time to begin understanding the complex genetic and epigenetic interactions at the basis of the human mind.
-
PJ Utz
Professor of Medicine (Immunology and Rheumatology)
Current Research and Scholarly InterestsThe long-term research goal of the Utz laboratory is to understand autoimmunity, autoantibodies, and how tolerance is broken and can be reestablished.
